Press release

Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference

CANTON, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the

articleOrganogenesis Holdings Inc.October 27, 20213/company/organogenesis-holdings-inc/news/organogenesis-showcases-latest-advanced-wound-care-innovations-and-research-at-sawc-0
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference

About this update from Organogenesis Holdings Inc.

[{"type":"text","content":"CANTON, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that the latest advanced wound care research on its PuraPly® AM, Affinity®, Apligraf®, and NuShield® product lines will be showcased at the 2021 Symposium on Advanced Wound Care (SAWC) Fall Conference held October 29-31 in Las Vegas, Nev. Attendees of this year’s event are encouraged to visit the Organogenesis-supported lunch symposium, “New Scientific Data Supporting the Use of an Antimicrobial Native Collagen ECM and Real-World Case Studies Highlighting a Treatment Algorithm Approach​” held Friday, Oct. 29, from 11:40 a.m. - 1:10 p.m. PST in the Innovation Theatre. The lunch symposium will feature a presentation by Katie Mowry, Ph.D, Assistant Vice President of Research and Development at Organogenesis, who will present in vivo data that supports the use of the company’s PuraPly technology as an antimicrobial barrier in the early stages of the healing process. Attendees will also hear from Dan Kapp, MD of Palm Beach Gardens Medical Center, who will share his clinical experience using innovative solutions to improve outcomes in complex wounds. Dr. Kapp is the Division Director of Plastic Surgery and Past Chief of Surgery at Palm Beach Gardens Medical Center and a Diplomate of the American Board of Plastic Surgery. As a lead sponsor of this year's meeting, Organogenesis will also support the presentation, “Leveraging Dermal Substitutes Post-Mohs Surgery: An Exploration of Surgical Technique and Post-Surgery Wound Care” held Saturday, Oct. 30, from 7:30 a.m. – 9 a.m. PST. Anthony Benedetto, DO, FACP, founder and medical director of the Dermatologic SurgiCenter in Philadelphia, will present his experience using dermal substitutes in Post-Mohs surgeries and post-surgery wound care. Attendees are encouraged to visit the Organogenesis exhibit hall booth (#501) to learn more about the latest advanced wound care products and latest studies. The Organogenesis Adjustable Curette will be available for debridement demonstrations and hands-on experience. Featuring a dual-edge adjustable blade, built-in ruler and contoured grip, this new product ...

More updates from Organogenesis Holdings Inc.